These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 398207

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Specific antitoxic therapy of botulism].
    Nikiforov VN, Nikiforov VV, Glukhikh OA, Tashpulatov ShA.
    Sov Med; 1985; (10):46-50. PubMed ID: 3909448
    [No Abstract] [Full Text] [Related]

  • 3. Immunological heterogeneity of Clostridium botulinum type B toxins.
    Shimizu T, Kondo H, Sakaguchi G.
    Jpn J Med Sci Biol; 1974 Apr; 27(2):99-100. PubMed ID: 4134872
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Toxoids of botulinum toxin type G].
    Puig de Centorbi ON, Ciccarelli AS, Giménez DF.
    Rev Argent Microbiol; 1980 Apr; 12(1):10-7. PubMed ID: 6755549
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [First outbreak of botulism caused by Clostridium botulinum subtype Af].
    Fernández RA, Ciccarelli AS, Arenas GN, Giménez DF.
    Rev Argent Microbiol; 1986 Apr; 18(1):29-31. PubMed ID: 3317514
    [Abstract] [Full Text] [Related]

  • 10. Differences in immunological responses of polyclonal botulinum A1 and A2 antitoxin against A1 and A2 toxin.
    Torii Y, Shinmura M, Kohda T, Kozaki S, Takahashi M, Ginnaga A.
    Toxicon; 2013 Oct; 73():9-16. PubMed ID: 23834917
    [Abstract] [Full Text] [Related]

  • 11. Chemiluminescence immunosorbent assay (CLISA) and a possibility of the specific detection of soluble antigens of Clostridium botulinum type A.
    Ligieza J, Reiss J, Michalik M.
    Arch Immunol Ther Exp (Warsz); 1994 Oct; 42(2):129-33. PubMed ID: 7503646
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Phenotypic characterization of Clostridium botulinum strains isolated from infant botulism cases in Argentina.
    Sagua MD, Lúquez C, Barzola CP, Bianco MI, Fernández RA.
    Rev Argent Microbiol; 2009 Oct; 41(3):141-7. PubMed ID: 19831311
    [Abstract] [Full Text] [Related]

  • 15. Development of antitoxin with each of two complementary fragments of Clostridium botulinum type B derivative toxin.
    Kozaki S, Miyazaki S, Sakaguchi G.
    Infect Immun; 1977 Dec; 18(3):761-6. PubMed ID: 412790
    [Abstract] [Full Text] [Related]

  • 16. [Induction and modulation of humoral immunity in mice by local nasal administration of botulinum toxoid type B].
    Hörmeyer E, Schultz A, Sailer J, Opitz G, Stünkel K, Petzoldt K.
    Berl Munch Tierarztl Wochenschr; 1985 Jan 01; 98(1):16-9. PubMed ID: 3885940
    [No Abstract] [Full Text] [Related]

  • 17. [Value of the immunofluorescence test in the diagnosis of botulinum toxin poisoning in humans and animals. I. Identification of Clostridium botulinum type A, B, E, F and C in artificially infected industrial preserves by the indirect and direct immunofluorescence test].
    Anusz Z, Mierzejewski J, Skoczek A.
    Przegl Epidemiol; 1973 Jan 01; 27(2):173-81. PubMed ID: 4578517
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. New targets in the search for preventive and therapeutic agents for botulism.
    Anniballi F, Lonati D, Fiore A, Auricchio B, De Medici D, Locatelli CA.
    Expert Rev Anti Infect Ther; 2014 Sep 01; 12(9):1075-86. PubMed ID: 25089560
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.